Global and Region Patient Derived Xenograft/PDX Models Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Patient Derived Xenograft/PDX Models market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Patient Derived Xenograft/PDX Modelsmarket, defines the market attractiveness level of Patient Derived Xenograft/PDX Models market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Patient Derived Xenograft/PDX Models industry, describes the types of Patient Derived Xenograft/PDX Models market, the applications of major players and the market size, and deeply analyzes the current situation of the global Patient Derived Xenograft/PDX Models market and the development prospects and opportunities of Patient Derived Xenograft/PDX Models industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Patient Derived Xenograft/PDX Models market in Chapter 13.

    By Player:

    • Charles River Laboratories

    • The Jackson Laboratory

    • Champions Oncology

    • Urolead

    • Hera Biolabs

    • Crown Bioscience

    • Pharmatest Services

    • Xentech

    • Horizon Discovery

    • WuXi Apptec

    • EPO Berlin-Buch

    • Oncodesign

    By Type:

    • Mice Models

    • Rat Models

    By End-User:

    • Pre-clinical Drug Development and Basic Cancer Research

    • Biomarker Analysis

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Patient Derived Xenograft/PDX Models Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Patient Derived Xenograft/PDX Models Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Patient Derived Xenograft/PDX Models Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Patient Derived Xenograft/PDX Models Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Patient Derived Xenograft/PDX Models Market Analysis and Outlook to 2022

    • 7.1 Global Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.2 United States Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.3 Europe Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.4 China Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.5 Japan Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.6 India Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    • 7.7 South Korea Patient Derived Xenograft/PDX Models Consumption (2017-2022)

    8 Region and Country-wise Patient Derived Xenograft/PDX Models Market Analysis and Outlook to 2028

    • 8.1 Global Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.2 United States Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.3 Europe Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.4 China Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.5 Japan Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.6 India Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    • 8.7 South Korea Patient Derived Xenograft/PDX Models Consumption Forecast (2022-2028)

    9 Global Patient Derived Xenograft/PDX Models Market Outlook by Types and Applications to 2022

    • 9.1 Global Patient Derived Xenograft/PDX Models Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mice Models Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Rat Models Consumption and Growth Rate (2017-2022)

    • 9.2 Global Patient Derived Xenograft/PDX Models Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pre-clinical Drug Development and Basic Cancer Research Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Biomarker Analysis Consumption and Growth Rate (2017-2022)

    10 Global Patient Derived Xenograft/PDX Models Market Outlook by Types and Applications to 2028

    • 10.1 Global Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Mice Models Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Rat Models Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pre-clinical Drug Development and Basic Cancer Research Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Biomarker Analysis Consumption Forecast and Growth Rate (2022-2028)

    11 Global Patient Derived Xenograft/PDX Models Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Patient Derived Xenograft/PDX Models Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Patient Derived Xenograft/PDX Models Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Patient Derived Xenograft/PDX Models Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Patient Derived Xenograft/PDX Models Market Competitive Analysis

    • 14.1 Charles River Laboratories

      • 14.1.1 Charles River Laboratories Company Details

      • 14.1.2 Charles River Laboratories Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Product and Service

    • 14.2 The Jackson Laboratory

      • 14.2.1 The Jackson Laboratory Company Details

      • 14.2.2 The Jackson Laboratory Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Product and Service

    • 14.3 Champions Oncology

      • 14.3.1 Champions Oncology Company Details

      • 14.3.2 Champions Oncology Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Product and Service

    • 14.4 Urolead

      • 14.4.1 Urolead Company Details

      • 14.4.2 Urolead Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Urolead Patient Derived Xenograft/PDX Models Product and Service

    • 14.5 Hera Biolabs

      • 14.5.1 Hera Biolabs Company Details

      • 14.5.2 Hera Biolabs Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hera Biolabs Patient Derived Xenograft/PDX Models Product and Service

    • 14.6 Crown Bioscience

      • 14.6.1 Crown Bioscience Company Details

      • 14.6.2 Crown Bioscience Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Crown Bioscience Patient Derived Xenograft/PDX Models Product and Service

    • 14.7 Pharmatest Services

      • 14.7.1 Pharmatest Services Company Details

      • 14.7.2 Pharmatest Services Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pharmatest Services Patient Derived Xenograft/PDX Models Product and Service

    • 14.8 Xentech

      • 14.8.1 Xentech Company Details

      • 14.8.2 Xentech Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Xentech Patient Derived Xenograft/PDX Models Product and Service

    • 14.9 Horizon Discovery

      • 14.9.1 Horizon Discovery Company Details

      • 14.9.2 Horizon Discovery Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Horizon Discovery Patient Derived Xenograft/PDX Models Product and Service

    • 14.10 WuXi Apptec

      • 14.10.1 WuXi Apptec Company Details

      • 14.10.2 WuXi Apptec Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 WuXi Apptec Patient Derived Xenograft/PDX Models Product and Service

    • 14.11 EPO Berlin-Buch

      • 14.11.1 EPO Berlin-Buch Company Details

      • 14.11.2 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Product and Service

    • 14.12 Oncodesign

      • 14.12.1 Oncodesign Company Details

      • 14.12.2 Oncodesign Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Oncodesign Patient Derived Xenograft/PDX Models Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Patient Derived Xenograft/PDX Models

    • Figure Patient Derived Xenograft/PDX Models Picture

    • Table Global Patient Derived Xenograft/PDX Models Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Patient Derived Xenograft/PDX Models Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Patient Derived Xenograft/PDX Models Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Patient Derived Xenograft/PDX Models Consumption by Country (2017-2022)

    • Figure United States Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Table Europe Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Figure China Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Figure Japan Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Figure India Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Figure South Korea Patient Derived Xenograft/PDX Models Consumption and Growth Rate (2017-2022)

    • Figure Global Patient Derived Xenograft/PDX Models Consumption Forecast by Country (2022-2028)

    • Figure United States Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Patient Derived Xenograft/PDX Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mice Models Consumption and Growth Rate (2017-2022)

    • Figure Global Rat Models Consumption and Growth Rate (2017-2022)

    • Figure Global Pre-clinical Drug Development and Basic Cancer Research Consumption and Growth Rate (2017-2022)

    • Figure Global Biomarker Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Mice Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rat Models Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pre-clinical Drug Development and Basic Cancer Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biomarker Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Patient Derived Xenograft/PDX Models Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Patient Derived Xenograft/PDX Models Export by Region (Top 5 Countries) (2017-2028)

    • Table Charles River Laboratories (Foundation Year, Company Profile and etc.)

    • Table Charles River Laboratories Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Charles River Laboratories Patient Derived Xenograft/PDX Models Product and Service

    • Table The Jackson Laboratory (Foundation Year, Company Profile and etc.)

    • Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Jackson Laboratory Patient Derived Xenograft/PDX Models Product and Service

    • Table Champions Oncology (Foundation Year, Company Profile and etc.)

    • Table Champions Oncology Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Champions Oncology Patient Derived Xenograft/PDX Models Product and Service

    • Table Urolead (Foundation Year, Company Profile and etc.)

    • Table Urolead Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Urolead Patient Derived Xenograft/PDX Models Product and Service

    • Table Hera Biolabs (Foundation Year, Company Profile and etc.)

    • Table Hera Biolabs Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hera Biolabs Patient Derived Xenograft/PDX Models Product and Service

    • Table Crown Bioscience (Foundation Year, Company Profile and etc.)

    • Table Crown Bioscience Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crown Bioscience Patient Derived Xenograft/PDX Models Product and Service

    • Table Pharmatest Services (Foundation Year, Company Profile and etc.)

    • Table Pharmatest Services Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmatest Services Patient Derived Xenograft/PDX Models Product and Service

    • Table Xentech (Foundation Year, Company Profile and etc.)

    • Table Xentech Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xentech Patient Derived Xenograft/PDX Models Product and Service

    • Table Horizon Discovery (Foundation Year, Company Profile and etc.)

    • Table Horizon Discovery Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Horizon Discovery Patient Derived Xenograft/PDX Models Product and Service

    • Table WuXi Apptec (Foundation Year, Company Profile and etc.)

    • Table WuXi Apptec Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table WuXi Apptec Patient Derived Xenograft/PDX Models Product and Service

    • Table EPO Berlin-Buch (Foundation Year, Company Profile and etc.)

    • Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table EPO Berlin-Buch Patient Derived Xenograft/PDX Models Product and Service

    • Table Oncodesign (Foundation Year, Company Profile and etc.)

    • Table Oncodesign Patient Derived Xenograft/PDX Models Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oncodesign Patient Derived Xenograft/PDX Models Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.